glp-1 and chronic kidney disease Design discovery of a highly potent ultralong-acting and glucagon co-agonist for attenuating renal fibrosis CKJ REVIEW GLP-1 receptor agonists
Description
Gut glucagon, enteroglucagon, gut glucagonlike immunoreactivity, glicentin current status
Diabetes Metab Res Rev
That is, for sure, cause for alarm
Another hormone that is an important target for new drugs in diabetes and obesity is glucagon
Our creamy vanilla meal replacement takes the guesswork out of healthy eating
